As global markets continue to show resilience and growth stocks outpace value shares, Sweden's market is also benefiting from this positive sentiment. In this context, companies with high insider ownership often stand out as they signal strong confidence from those closest to the business.

Top 10 Growth Companies With High Insider Ownership In Sweden

Click here to see the full list of 93 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) is a Swedish company that develops biological drugs for central nervous system disorders and has a market cap of SEK14.05 billion.

Operations: BioArctic's revenue segment includes SEK252.21 million from its biotechnology division.

Insider Ownership: 34%

BioArctic's revenue is forecast to grow at 39.6% annually, outpacing the Swedish market and surpassing 20% per year. The company is expected to achieve profitability within three years, with earnings projected to grow by 102.8% annually. Despite recent high share price volatility, BioArctic trades at a significant discount to its estimated fair value and has seen insider buying in the last three months. Recent approvals of Leqembi for Alzheimer's treatment in multiple countries further bolster its growth prospects.

• Navigate through the intricacies of BioArctic with our comprehensive analyst estimates report here.

• Our expertly prepared valuation report BioArctic implies its share price may be lower than expected.

EQT

Simply Wall St Growth Rating: ★★★★★☆

Overview: EQT AB (publ) is a global private equity firm specializing in private capital and real asset segments, with a market cap of SEK405.21 billion.

Operations: The company's revenue segments include Central (€37.20 million), Real Assets (€878.70 million), and Private Capital (€1.28 billion).

Insider Ownership: 30.9%

EQT AB has shown substantial growth, with earnings increasing by 384.2% over the past year and revenue expected to grow at 17.9% annually, outpacing the Swedish market. Despite significant insider selling recently, the company's high insider ownership aligns interests with shareholders. EQT is actively pursuing strategic acquisitions, including potential bids for Compass Education and JB Chemicals & Pharmaceuticals. The firm also initiated a share repurchase program to optimize capital structure and support future growth initiatives.

• Take a closer look at EQT's potential here in our earnings growth report.

• Our comprehensive valuation report raises the possibility that EQT is priced higher than what may be justified by its financials.

Medicover

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK27.63 billion.

Operations: Medicover generates revenue primarily through its Healthcare Services (€1.32 billion) and Diagnostic Services (€610 million) segments.

Insider Ownership: 11.1%

Medicover AB has demonstrated robust growth, with earnings rising by 327.8% over the past year and revenue forecasted to grow at 14% annually, surpassing the Swedish market's average. Insider ownership is high, aligning management's interests with shareholders. Recent executive changes include Anand Patel joining as CFO in October 2024, bringing extensive retail sector experience. Despite low substantial insider buying recently, Medicover remains financially strong but faces challenges in covering interest payments with earnings.

• Click to explore a detailed breakdown of our findings in Medicover's earnings growth report.

• Our valuation report here indicates Medicover may be overvalued.

Summing It All Up

• Unlock our comprehensive list of 93 Fast Growing Swedish Companies With High Insider Ownership by clicking here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:BIOA B OM:EQT and OM:MCOV B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com